Actuate Therapeutics ACTU
NASDAQ ACTU
$0.52 -0.05 (-8.18%)
At close: Oct 22, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) EBT (2023 - 2026)

Updated

Actuate Therapeutics' EBT was -$4.87 million in Q2 2026, compared with -$5.95 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) EBT (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actuate Therapeutics' EBT was -$20.78 million through Jun 30, 2026; for FY2025, it came in at -$22.23 million.

  • In earlier years, EBT was -$24.96 million in FY2024 and -$24.66 million in FY2023.
  • Quarterly EBT has moved between -$7.76 million (Q1 2024) and -$4.55 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 34.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 4.28 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.80 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -653.00 Mn
10 Actuate Therapeutics 11.58 Mn -29.42 Mn - -4.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.87 Mn
Dec 31, 2025 -4.55 Mn
Sep 30, 2025 -5.41 Mn
Jun 30, 2025 -5.95 Mn
Mar 31, 2025 -6.32 Mn
Dec 31, 2024 -6.45 Mn
Sep 30, 2024 -5.32 Mn
Jun 30, 2024 -5.43 Mn
Mar 31, 2024 -7.76 Mn
Dec 31, 2023 -7.56 Mn
Sep 30, 2023 -6.35 Mn
Jun 30, 2023 -5.59 Mn
API Access

Actuate Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ACTU&period=max&api_key=YOUR_API_KEY